p16(CDKN2) gene polymorphism:: association with histologic subtypes of epithelial ovarian cancer in China

被引:18
|
作者
Yan, L. [1 ,2 ]
Na, W. [2 ]
Shan, K. [3 ]
Xiao-Wei, M. [3 ]
Wei, G. [2 ]
Shu-Cheng, C. [3 ]
机构
[1] Hebei Med Univ, Hosp 4, Hebei Canc Inst, Shijiazhuang 050011, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Mol Biol, Shijiazhuang 050011, Peoples R China
[3] Hebei Med Univ, Hosp 4, Dept Obstet & Gynaecol, Shijiazhuang 050011, Peoples R China
基金
美国国家科学基金会;
关键词
epithelial ovarian cancer; haplotype; p16; single nucleotide polymorphism; susceptibility;
D O I
10.1111/j.1525-1438.2007.00953.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p16 is an important tumor suppressor gene, which is inactivated in many kinds of tumors. The common variants of p16 may be associated with the risk of certain tumors development. We analyzed the frequency of two adjacent polymorphisms in p16 exon 3 (540C -> G and 580C -> T) and their haplotype in blood samples from epithelial ovarian cancer (EOC) patients and healthy controls using polymerase chain reaction-restriction fragment length polymorphism. The results showed that the genotype frequency of p16 580C -> T polymorphism was significantly different among histologic subtypes of EOC (P = 0.02). T allele carriers significantly reduced the risk of serous EOC; the adjusted odds ratio was 0.40 (95% CI = 0.19-0.84). There are neither association between p16 540C -> G polymorphism and EOC development, progression, nor association between the haplotypes of two single nucleotide polymorphisms and the tumor development. Our results suggested that the p16 580C -> T polymorphism might affect the individual susceptibility to specific subtypes of EOC. Different types of ovarian cancer might adopt distinct carcinogenetic pathways. However, this result may be further validated in a larger sample of patients.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [31] CHROMOSOME 9P ALLELIC LOSS AND P16/CDKN2 IN BREAST-CANCER AND EVIDENCE OF P16 INACTIVATION IN IMMORTAL BREAST EPITHELIAL-CELLS
    BRENNER, AJ
    ALDAZ, CM
    [J]. CANCER RESEARCH, 1995, 55 (13) : 2892 - 2895
  • [32] Homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in mouse liver epithelial cells in culture
    Miyasaka, K
    Kawauchi, S
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (03) : 345 - 349
  • [33] Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines
    Yoshinouchi, M
    Hongo, A
    Takamoto, N
    Ono, Y
    Nagao, S
    Miyagi, Y
    Kudo, T
    Kodama, J
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (03) : 537 - 541
  • [34] ALTERATIONS OF CDKN2 (P16) IN NON-SMALL-CELL LUNG-CANCER
    DEVOS, S
    MILLER, CW
    TAKEUCHI, S
    GOMBART, AF
    CHO, SK
    KOEFFLER, HP
    [J]. GENES CHROMOSOMES & CANCER, 1995, 14 (03): : 164 - 170
  • [35] p16(MTS-1/CDKN2/INK4a) in cancer progression
    Rocco, JW
    Sidransky, D
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) : 42 - 55
  • [36] INFREQUENT CDKN2 (MTS1/P16) GENE ALTERATIONS IN HUMAN PRIMARY BREAST-CANCER
    BERNS, EMJJ
    KLIJN, JGM
    SMID, M
    VANSTAVEREN, IL
    GRUIS, NA
    FOEKENS, JA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 964 - 967
  • [37] ANALYSIS OF THE P16 GENE (CDKN2) AS A CANDIDATE FOR THE CHROMOSOME 9P MELANOMA SUSCEPTIBILITY LOCUS
    KAMB, A
    SHATTUCKEIDENS, D
    EELES, R
    LIU, Q
    GRUIS, NA
    DING, W
    HUSSEY, C
    TRAN, T
    MIKI, Y
    WEAVERFELDHAUS, J
    MCCLURE, M
    AITKEN, JF
    ANDERSON, DE
    BERGMAN, W
    FRANTS, R
    GOLDGAR, DE
    GREEN, A
    MACLENNAN, R
    MARTIN, NG
    MEYER, LJ
    YOUL, P
    ZONE, JJ
    SKOLNICK, MH
    CANNONALBRIGHT, LA
    [J]. NATURE GENETICS, 1994, 8 (01) : 22 - 26
  • [38] Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro
    Chintala, SK
    Fueyo, J
    GomezManzano, C
    Venkaiah, B
    Bjerkvig, R
    Yung, WKA
    Sawaya, R
    Kyritsis, AP
    Rao, JS
    [J]. ONCOGENE, 1997, 15 (17) : 2049 - 2057
  • [39] Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus
    Giroux, MA
    Audrezet, MP
    Metges, JP
    Lozac'h, P
    Volant, A
    Nousbaum, JB
    Labat, JP
    Gouérou, H
    Ferec, C
    Robaszkiewicz, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (01) : 15 - 18
  • [40] Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro
    Shravan K Chintala
    Juan Fueyo
    Candelaria Gomez-Manzano
    Boyapati Venkaiah
    Rolf Bjerkvig
    WK Alfred Yung
    Raymond Sawaya
    Athanassios P Kyritsis
    Jasti S Rao
    [J]. Oncogene, 1997, 15 : 2049 - 2057